Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity

Autor: Hyun-A Kim, H. Lee, Yong-Ho Jung, Sang Won Park, J. S. Son, Nam Joong Kim, Won Sup Oh, Won Suk Choi, Ju-Hyeon Choi, Yeon Sook Kim, Chan-Sub Kim, Ju-Young Yoon, H. Y. Seol, J. H. Lee, Hee-Chang Jang, Sungman Park, Sukjae Jeong, Yong-Su Choi, Sang-Sam Choi, Heungjeong Woo, Kyo-Young Lee, Jung-Ran Choi, Hyukjae Choi, Ji Hwan Bang, Sun-Mi Choi, Jinseon Kim, Sungmin Kiem, Sung Hwan Park, Jeewon Rhee, Kye-Hyung Kim, Yu Mi Wi, Eu Suk Kim, Baek-Nam Kim
Rok vydání: 2016
Předmět:
Adult
Male
0301 basic medicine
Microbiology (medical)
medicine.medical_specialty
Infectious Disease Transmission
Patient-to-Professional

Adolescent
IgG
Middle East respiratory syndrome coronavirus
Health Personnel
health care facilities
manpower
and services

education
030106 microbiology
medicine.disease_cause
Article
Serology
Young Adult
03 medical and health sciences
0302 clinical medicine
Seroepidemiologic Studies
Personal protective equipment
Internal medicine
medicine
Healthcare personnel
Humans
Seroprevalence
030212 general & internal medicine
Aged
Indirect immunofluorescence
Transmission (medicine)
business.industry
Incidence
Middle East respiratory syndrome
Incidence (epidemiology)
virus diseases
General Medicine
Middle Aged
medicine.disease
Health Surveys
Virology
Infectious Diseases
Population Surveillance
Middle East Respiratory Syndrome Coronavirus
Female
Coronavirus Infections
business
Zdroj: Clinical Microbiology and Infection
ISSN: 1198-743X
Popis: Given the mode of transmission of Middle East respiratory syndrome (MERS), healthcare workers (HCWs) in contact with MERS patients are expected to be at risk of MERS infections. We evaluated the prevalence of MERS coronavirus (CoV) immunoglobulin (Ig) G in HCWs exposed to MERS patients and calculated the incidence of MERS-affected cases in HCWs. We enrolled HCWs from hospitals where confirmed MERS patients had visited. Serum was collected 4 to 6 weeks after the last contact with a confirmed MERS patient. We performed an enzyme-linked immunosorbent assay (ELISA) to screen for the presence of MERS-CoV IgG and an indirect immunofluorescence test (IIFT) to confirm MERS-CoV IgG. We used a questionnaire to collect information regarding the exposure. We calculated the incidence of MERS-affected cases by dividing the sum of PCR-confirmed and serology-confirmed cases by the number of exposed HCWs in participating hospitals. In total, 1169 HCWs in 31 hospitals had contact with 114 MERS patients, and among the HCWs, 15 were PCR-confirmed MERS cases in study hospitals. Serologic analysis was performed for 737 participants. ELISA was positive in five participants and borderline for seven. IIFT was positive for two (0.3%) of these 12 participants. Among the participants who did not use appropriate personal protective equipment (PPE), seropositivity was 0.7% (2/294) compared to 0% (0/443) in cases with appropriate PPE use. The incidence of MERS infection in HCWs was 1.5% (17/1169). The seroprevalence of MERS-CoV IgG among HCWs was higher among participants who did not use appropriate PPE.
Databáze: OpenAIRE